Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison.
Raymond WongJesse FishmanKoo WilsonMichael YehMohammed Al-AdhamiAbigail ZionChristopher W YeeLynn HuynhMei Sheng DuhPublished in: Advances in therapy (2023)
ClinicalTrials.gov identifier, NCT04085601.